As U.S. Takes Aim at China Drug Makers, Innovators Appear at Biggest Risk
美國製裁瞄準中國藥企，創新藥企業面臨最大風險

Washington’s campaign to keep cutting-edge technology out of China took a new twist late last week with the addition of Chinese medical companies to U.S. blacklists.
隨著中國的醫藥公司列入美國實體清單，華盛頓阻止尖端技術進入中國的行動出現了新走向，自主研發藥物的公司在以後會面臨更大壓力。